Stock comparison
Koninklijke Philips N.V.
ResMed
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
PHG
Koninklijke Philips N.V.
Market cap
$25.66B
Sector
Healthcare
RMD
ResMed
Market cap
$30.18B
Sector
Healthcare
Overall winner
ResMed RMD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | PHG | RMD | Winner |
|---|---|---|---|
| Warren Buffett | 38D | 72B | RMD |
| Benjamin Graham | 36D | 75B | RMD |
| Philip Fisher | 38D | 75B | RMD |
| Peter Lynch | 44D | 58C | RMD |
| Joel Greenblatt | 30F | 47D | RMD |
| Charlie Munger | 36D | 69B | RMD |
| Terry Smith | 33F | 73B | RMD |
Side-by-side metrics
| Metric | PHG | RMD |
|---|---|---|
| Market cap | $25.66B | $30.18B |
| P/E (TTM) | 21.4x | 19.6x |
| EV/EBIT | 18.5x | 17.1x |
| ROIC (TTM) | 5.76% | 19.63% |
| Gross margin | 45.2% | 61.69% |
| Net margin | 5.5% | 27.44% |
| Revenue CAGR 5y | 0.97% | 12.64% |
| EPS CAGR 5y | 9.12% | 30.73% |
| Debt / Equity | 0.7x | 0.1x |
| Dividend yield | 3.89% | 1.14% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
PHG leads on
- Dividend yield3.89%vs 1.14%+71%
RMD leads on
- Revenue CAGR 5y12.64%vs 0.97%+92%
- Debt / Equity0.1xvs 0.7x+82%
- Net margin27.44%vs 5.5%+80%
- ROIC (TTM)19.63%vs 5.76%+71%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.